MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

LivaNova PLC

Затворен

64.05 -1.19

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

63.86

Максимум

64.88

Ключови измерители

By Trading Economics

Приходи

-377K

27M

Продажби

5.3M

358M

Марж на печалбата

7.486

Служители

2,900

EBITDA

2.8M

57M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+11.62% upside

Дивиденти

By Dow Jones

Следващи печалби

24.02.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

582M

3.5B

Предишно отваряне

65.24

Предишно затваряне

64.05

Техническа оценка

By Trading Central

Увереност

Weak Bullish Evidence

LivaNova PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.01.2026 г., 22:18 ч. UTC

Пазарно говорене

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

9.01.2026 г., 21:50 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

9.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

9.01.2026 г., 21:43 ч. UTC

Печалби
Придобивния, сливания и поглъщания

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9.01.2026 г., 20:39 ч. UTC

Пазарно говорене

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9.01.2026 г., 20:38 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9.01.2026 г., 20:36 ч. UTC

Придобивния, сливания и поглъщания

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9.01.2026 г., 20:30 ч. UTC

Пазарно говорене

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9.01.2026 г., 20:15 ч. UTC

Пазарно говорене

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9.01.2026 г., 20:07 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

9.01.2026 г., 20:07 ч. UTC

Пазарно говорене

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9.01.2026 г., 19:58 ч. UTC

Придобивния, сливания и поглъщания

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9.01.2026 г., 19:42 ч. UTC

Пазарно говорене

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9.01.2026 г., 19:38 ч. UTC

Придобивния, сливания и поглъщания

Wolters Kluwer Acquires StandardFusion >WTKWY

9.01.2026 г., 19:31 ч. UTC

Печалби

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9.01.2026 г., 19:28 ч. UTC

Печалби

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9.01.2026 г., 18:30 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9.01.2026 г., 18:23 ч. UTC

Пазарно говорене

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9.01.2026 г., 17:20 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

9.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.01.2026 г., 17:19 ч. UTC

Пазарно говорене

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9.01.2026 г., 17:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

9.01.2026 г., 17:07 ч. UTC

Пазарно говорене

McDonald's Promotions Appear Successful -- Market Talk

9.01.2026 г., 17:06 ч. UTC

Пазарно говорене

Oil Futures on Track for Weekly Gains -- Market Talk

9.01.2026 г., 17:05 ч. UTC

Печалби

Stocks Sail Past Jobs Data, Tariff Opinion Delay. Earnings Season Looms. -- Barrons.com

9.01.2026 г., 16:57 ч. UTC

Пазарно говорене

Energy Activity Tumbles in 4Q, KC Fed Survey Finds -- Market Talk

9.01.2026 г., 16:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

9.01.2026 г., 16:46 ч. UTC

Пазарно говорене

Dollar Could Stay Steady For Now, More Likely to Fall Than Rise -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

LivaNova PLC Прогноза

Ценова цел

By TipRanks

11.62% нагоре

12-месечна прогноза

Среден 72.5 USD  11.62%

Висок 85 USD

Нисък 64 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за LivaNova PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

6

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

36.34 / N/AПодкрепа & съпротива

Краткосрочен план

Weak Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
help-icon Live chat